The metal binding affinity of an (N2S2)Ni bridging metallothiolate ligand (Zn2+ < Ni2+ < Cu+) gives precedent for the observed heterogeneity in ACS/CODH.
No takes yet. Share an insight, caveat, or question.
Golden et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: